Viewing StudyNCT04933942



Ignite Creation Date: 2024-05-06 @ 4:17 PM
Last Modification Date: 2024-10-26 @ 2:07 PM
Study NCT ID: NCT04933942
Status: WITHDRAWN
Last Update Posted: 2023-05-24
First Post: 2021-06-14

Brief Title: Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization: European Organisation for Research and Treatment of Cancer - EORTC

Conditions & Keywords Data

Conditions:
Name
First Progression of MGMT Promoter-methylated Glioblastoma
Keywords:
Name View
Lomustine View
First progression View
MGMT promoter-methylated glioblastoma View
Phase II View
Romiplostim View